Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study

Area of Science:

• Neuroscience
• Rehabilitation Medicine
• Pharmacology

Background:

• Stroke rehabilitation aims to restore function and improve quality of life.
• Early intervention is crucial for optimizing recovery outcomes.
• Pharmacological agents may play a role in augmenting traditional rehabilitation therapies.

Purpose of the Study:

• To evaluate the efficacy and safety of methylphenidate as an adjunct therapy in acute stroke rehabilitation.
• To determine if methylphenidate can enhance mood, cognitive, and motor recovery post-stroke.

Main Methods:

• A prospective, randomized, double-blind, placebo-controlled study involving 21 stroke patients.
• Participants received either methylphenidate (gradually increased to 30mg daily) or placebo for three weeks alongside physical therapy.
• Mood (HAM-D, ZDS), cognition (MMSE), and motor function (FMS, M-FIM) were assessed weekly.

Main Results:

• Methylphenidate group showed significant improvements in mood, with lower scores on the Hamilton Depression Rating Scale (HAM-D) and Zung Self-Rating Depression Scale (ZDS).
• Patients treated with methylphenidate demonstrated enhanced motor function, indicated by higher scores on the modified Functional Independence Measure (M-FIM) and Fugl-Meyer Scale (FMS).
• No significant adverse events were reported, suggesting a favorable safety profile.

Conclusions:

• Methylphenidate is a safe and effective intervention for early poststroke rehabilitation.
• The use of methylphenidate may expedite the recovery process in stroke patients.
• Further research is warranted to explore long-term effects and optimal dosing strategies.